Patent · US Active

Anti-VEGF protein compositions and methods for producing the same

US11180540B2 · kind B2 · utility

2Cited by

66References

28Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Andrew Tustian · Millwood, US
Ankit Vartak · Elmsford, US
Thomas Daly · New City, US
Erica Pyles · New City, US
Nisha Palackal · White Plains, US
Shunhai Wang · Scarsdale, US
Ning Li · New Canaan, US
Matthew C. Franklin · Great Neck, US

Key dates

Filing date	Aug 18, 2020
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Aug 18, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2030/027
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.